10
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Clinical, Endocrine, and Molecular Genetic Analysis of a Large Cohort of Saudi Arabian Patients with Laron Syndrome

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background/Aims: Laron syndrome (LS) is an autosomal recessive disease characterized by marked short stature and very low serum IGF-1<sup></sup> and IGFBP-3 levels. This study assessed the clinical and endocrine features alongside determining the growth hormone receptor gene ( GHR) mutation in Saudi Arabian patients with LS in order to establish whether or not a genotype/phenotype correlation is evident in this large cohort. Subjects and Methods: A total of 40 Saudi Arabian patients with a suspected diagnosis of LS were recruited and subjected to a full clinical and endocrine investigation together with direct sequencing of the coding regions of the GHR gene. Results: GHR mutations were identified in 34 patients from 22 separate nuclear families. All 34 molecularly confirmed patients had the typical clinical and endocrinological manifestations of LS. Eleven different mutations (9 previously unreported) were detected in this cohort of patients, all inherited in an autosomal recessive homozygous form. No genotype/phenotype correlation was apparent. Conclusion: The identification of pathogenic mutations causing LS will be of tremendous use for the molecular diagnosis of patients in Saudi Arabia and the region in general, with respect to prevention of this disease in the forms of future carrier testing, prenatal testing, premarital screening and preimplantation genetic diagnosis.

          Related collections

          Author and article information

          Journal
          HRP
          Horm Res Paediatr
          10.1159/issn.1663-2818
          Hormone Research in Paediatrics
          S. Karger AG
          1663-2818
          1663-2826
          2017
          September 2017
          25 July 2017
          : 88
          : 2
          : 119-126
          Affiliations
          [_a] aDepartment of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
          [_b] bDepartment of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
          [_c] cDepartment of Medical Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
          Author notes
          *Faiqa Imtiaz, PhD, Department of Genetics, King Faisal Specialist Hospital and Research Center, PO Box 3354, MBC-03, Riyadh 11211 (Saudi Arabia), E-Mail fahmad@kfshrc.edu.sa
          Article
          475991 Horm Res Paediatr 2017;88:119–126
          10.1159/000475991
          28743110
          caaee311-7665-42f1-8e90-e5d16b4cbd7d
          © 2017 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 16 December 2016
          : 24 April 2017
          Page count
          Figures: 2, Tables: 3, Pages: 8
          Categories
          Original Paper

          Endocrinology & Diabetes,Neurology,Nutrition & Dietetics,Sexual medicine,Internal medicine,Pharmacology & Pharmaceutical medicine
          Laron syndrome,Growth hormone receptor,Growth hormone insensitivity, GHR mutations

          Comments

          Comment on this article